Cookies

Like most websites The Medicine Maker uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.

Business Practice

Discovery & Development Drug Discovery

Staying on the Track to Eradication

| Rosanne Rotondo

A diverse range of malaria treatments will make all the difference in the prevention of resistance.

Discovery & Development Clinical Trials

Malaysia in the Middle: Tackling Hep C in an Unfair World

| Angus Stewart

How the Drugs for Neglected Diseases Initiative and the Malaysian government partnered to tackle hep C with an affordable, effective cure.

Manufacture Small Molecules

(Precious) Metal Will Never Die

| Sponsored by Sabin Metal

Precious metals-bearing catalysts are essential in some pharma processes – but, once they’re spent, they still hold value.

Business & Regulation Business Practice

A Hacker’s Dream

| Maryam Mahdi

What strategies can pharma employ to protect itself against cyber threats?

Business & Regulation Profession

So, You Want to Become a CDMO…

| Sharon Johnson

Looking to pivot your business model to a CDMO service offering? Here’s what to keep in mind.

Business & Regulation Small Molecules

The Lilly and the Kumquat

| Angus Stewart

Eli Lilly’s Loxo Oncology has signed a deal with Yi Liu’s Kumquat Biosciences, targeting novel small molecules for immuno-oncology.

Business & Regulation Profession

Leadership Star

Sitting Down With… Andrew Moore, General Manager of Pfizer CentreOne.

Business & Regulation Biosimilars

What Lies Ahead for Biosimilars?

| Stephanie Sutton

Sandoz’s Pierre Bourdage talks to us about biosimilars and how uptake can be boosted.

Business & Regulation Profession

Growing, Adapting, Leading

| Angus Stewart, Stephanie Sutton

We interview Mary Lavin, President of Sartorius North America, about her career.

Business & Regulation Business Practice

Come Get Your Leaves

| Angus Stewart

Andes-based cannabis cultivator Clever Leaves pledges to send US$25 million of leaves to US researchers.

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register